HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$7.41
Day range
$7.50 - $7.90
Year range
$3.76 - $13.69
Market cap
46.84M USD
Avg Volume
43.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 169.00K | -73.13% |
Operating expense | 4.94M | -4.19% |
Net income | -19.88M | 75.80% |
Net profit margin | -11.76K | 9.93% |
Earnings per share | -1.91 | 85.42% |
EBITDA | -21.56M | -6.08% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.84M | 36.71% |
Total assets | 88.53M | 26.31% |
Total liabilities | 34.99M | -64.68% |
Total equity | 53.54M | — |
Shares outstanding | 6.19M | — |
Price to book | 0.85 | — |
Return on assets | -55.00% | — |
Return on capital | -79.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -19.88M | 75.80% |
Cash from operations | -21.74M | -18.16% |
Cash from investing | -2.02M | -110.12% |
Cash from financing | 123.00K | 26.80% |
Net change in cash | -23.64M | -1,519.15% |
Free cash flow | -13.61M | -29.42% |
About
Founded
2018
Headquarters
Website
Employees
82
